EFFICACY OF RIFAXIMIN ON BLOATING IN PATIENTS WITH DIARRHOEA‐PREDOMINANT IRRITABLE BOWEL SYNDROME: A POOLED ANALYSIS OF THREE PHASE 3, RANDOMIZED, PLACEBO‐CONTROLLED TRIALS
Brian Lacy 1
Mark Pimentel 2
Christopher Chang 3
Zeev Heimanson 4
Anthony J. Lembo 5
1 Mayo Clinic Hospital,Jacksonville,United States
2 Cedars-Sinai Medical Center,Los Angeles,United States
3 New Mexico VA Health Care System,Albuquerque,United States
4 Salix Pharmaceuticals,Bridgewater,United States
5 Beth Israel Deaconess Medical Center,Boston,United States
Session
IBS II
Conference
UEG Week Virtual 2020
Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]